141 related articles for article (PubMed ID: 35870542)
1. A retrospective study of antivenom-associated adverse reaction and anaphylaxis at Ngwelezana Hospital, South Africa.
Giles T; Čačala SR; Wood D; Klopper J; Oosthuizen GV
Toxicon; 2022 Oct; 217():1-4. PubMed ID: 35870542
[TBL] [Abstract][Full Text] [Related]
2. Severe snakebites in northern KwaZulu-Natal: treatment modalities and outcomes.
Wood D; Webb C; DeMeyer J
S Afr Med J; 2009 Nov; 99(11):814-8. PubMed ID: 20218483
[TBL] [Abstract][Full Text] [Related]
3. Antivenom use, premedication and early adverse reactions in the management of snake bites in rural Papua New Guinea.
Williams DJ; Jensen SD; Nimorakiotakis B; Müller R; Winkel KD
Toxicon; 2007 May; 49(6):780-92. PubMed ID: 17210167
[TBL] [Abstract][Full Text] [Related]
4. Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis.
Isbister GK; Brown SG; MacDonald E; White J; Currie BJ;
Med J Aust; 2008 Apr; 188(8):473-6. PubMed ID: 18429716
[TBL] [Abstract][Full Text] [Related]
5. Prospective, consecutive case series of 158 snakebite patients treated at Savannakhet provincial hospital, Lao People's Democratic Republic with high incidence of anaphylactic shock to horse derived F(ab')2 antivenom.
Vongphoumy I; Chanthilat P; Vilayvong P; Blessmann J
Toxicon; 2016 Jul; 117():13-21. PubMed ID: 26995210
[TBL] [Abstract][Full Text] [Related]
6. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial.
de Silva HA; Pathmeswaran A; Ranasinha CD; Jayamanne S; Samarakoon SB; Hittharage A; Kalupahana R; Ratnatilaka GA; Uluwatthage W; Aronson JK; Armitage JM; Lalloo DG; de Silva HJ
PLoS Med; 2011 May; 8(5):e1000435. PubMed ID: 21572992
[TBL] [Abstract][Full Text] [Related]
7. High incidence of early anaphylactoid reaction to SAIMR polyvalent snake antivenom.
Moran NF; Newman WJ; Theakston RD; Warrell DA; Wilkinson D
Trans R Soc Trop Med Hyg; 1998; 92(1):69-70. PubMed ID: 9692158
[TBL] [Abstract][Full Text] [Related]
8. Estimating the Burden of Snakebite on Public Hospitals in KwaZulu Natal, South Africa.
Darryl W; Sartorius B; Hift R
Wilderness Environ Med; 2016 Mar; 27(1):53-61. PubMed ID: 26948554
[TBL] [Abstract][Full Text] [Related]
9. Prospective review of cytotoxic snakebite envenomation in a paediatric population.
Variawa S; Buitendag J; Marais R; Wood D; Oosthuizen G
Toxicon; 2021 Jan; 190():73-78. PubMed ID: 33340504
[TBL] [Abstract][Full Text] [Related]
10. A prospective cohort study of the effectiveness of the primary hospital management of all snakebites in Kurunegala district of Sri Lanka.
Shahmy S; Kularatne SAM; Rathnayake SS; Dawson AH
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005847. PubMed ID: 28827807
[TBL] [Abstract][Full Text] [Related]
11. Incidence of serum sickness following Indian polyvalent antivenom therapy in a cohort of snake-envenomed patients in rural Sri Lanka.
Waiddyanatha S; Silva A; Wedasingha S; Siribaddana S; Isbister GK
Clin Toxicol (Phila); 2023 Jul; 61(7):518-523. PubMed ID: 37486099
[TBL] [Abstract][Full Text] [Related]
12. Moderate-to-severe
Lamb T; Stewart D; Warrell DA; Lalloo DG; Jagpal P; Jones D; Thanacoody R; Gray LA; Eddleston M
Clin Toxicol (Phila); 2021 Nov; 59(11):992-1001. PubMed ID: 33720783
[TBL] [Abstract][Full Text] [Related]
13. Livestock herding and Fulani ethnicity are a combined risk factor for development of early adverse reactions to antivenom treatment: Findings from a cross-sectional study in Nigeria.
Menzies SK; Thomas AO; Tianyi FL; Abubakar SB; Nasidi A; Durfa N; Patel R; Trelfa A; Lalloo DG; Habib AG; Harrison RA
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009518. PubMed ID: 34383742
[TBL] [Abstract][Full Text] [Related]
14. Immune response to snake envenoming and treatment with antivenom; complement activation, cytokine production and mast cell degranulation.
Stone SF; Isbister GK; Shahmy S; Mohamed F; Abeysinghe C; Karunathilake H; Ariaratnam A; Jacoby-Alner TE; Cotterell CL; Brown SG
PLoS Negl Trop Dis; 2013; 7(7):e2326. PubMed ID: 23936562
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Allergic Reactions Following Intravenous Infusion of Polyvalent Antivenom in Snakebite Patients.
Mahmoudi GA; Ahadi M; Fouladvand A; Rezaei B; Bodagh Z; Astaraki P
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(4):367-372. PubMed ID: 33563188
[TBL] [Abstract][Full Text] [Related]
16. Treatment of the first known case of king cobra envenomation in the United Kingdom, complicated by severe anaphylaxis.
Veto T; Price R; Silsby JF; Carter JA
Anaesthesia; 2007 Jan; 62(1):75-8. PubMed ID: 17156231
[TBL] [Abstract][Full Text] [Related]
17. Adverse reactions to four types of monovalent antivenom used in the treatment of snakebite envenoming in South China.
Li Q; Zeng L; Deng H; Liang Q
Toxicon; 2022 Nov; 219():106935. PubMed ID: 36202177
[TBL] [Abstract][Full Text] [Related]
18. A comparison between adult and paediatric snakebites and their outcomes in North Eastern South Africa.
J B; S V; D W; Gv O
Toxicon; 2022 Mar; 208():13-17. PubMed ID: 34958821
[TBL] [Abstract][Full Text] [Related]
19. Incidence of immediate and delayed hypersensitivity to Centruroides antivenom.
LoVecchio F; Welch S; Klemens J; Curry SC; Thomas R
Ann Emerg Med; 1999 Nov; 34(5):615-9. PubMed ID: 10533009
[TBL] [Abstract][Full Text] [Related]
20. Severe adverse drug reaction following Crotalidae Polyvalent Immune Fab (Ovine) administration for copperhead snakebite.
Lepak MR; Bochenek SH; Bush SP
Ann Pharmacother; 2015 Jan; 49(1):145-9. PubMed ID: 25341425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
